Compare Payoneer Global Inc (PAYO) vs Sanofi SA (SNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Payoneer Global Inc vs Sanofi SA — how do they compare? Payoneer Global Inc trades at $7.13 (market cap $2.41B), while Sanofi SA trades at $43.89 (market cap $104.85B). The key difference: Sanofi SA is far larger — about 43.5× Payoneer Global Inc's market cap, and Sanofi SA pays a 5.53% dividend while Payoneer Global Inc pays none. Which is the better fit depends on your goals.
| PAYO | SNY | |
|---|---|---|
Market Cap | $2.41B | $104.85B |
Sector | Technology | Health |
52-Week High | $7.42 | $52.34 |
52-Week Low | $4.27 | $41.33 |
Enterprise Value | $2.15B | $121.38B |
Dividend Yield | — | 5.53% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Payoneer Global Inc
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
